Fredrik Rorsman

Dietary Habits of Individuals With Primary Sclerosing Cholangitis-Poor Fat-Soluble Vitamin Intake and Dietary Quality

Lindqvist, Catarina; Ingre, Michael; Kechagias, Stergios; Nilsson, Emma et al.

Ingår i Liver international, 2025

• DOI för Dietary Habits of Individuals With Primary Sclerosing Cholangitis-Poor Fat-Soluble Vitamin Intake and Dietary Quality
• Ladda ner fulltext (pdf) av Dietary Habits of Individuals With Primary Sclerosing Cholangitis-Poor Fat-Soluble Vitamin Intake and Dietary Quality

Effects of an anti-lipogenic low-carbohydrate high polyunsaturated fat diet or a healthy Nordic diet versus usual care on liver fat and cardiometabolic disorders in type 2 diabetes or prediabetes: a randomized controlled trial (NAFLDiet)

Fridén, Michael; Rosqvist, Fredrik; Kullberg, Joel; Berglund, Lars et al.

Ingår i Nature Communications, 2025

• DOI för Effects of an anti-lipogenic low-carbohydrate high polyunsaturated fat diet or a healthy Nordic diet versus usual care on liver fat and cardiometabolic disorders in type 2 diabetes or prediabetes: a randomized controlled trial (NAFLDiet)
• Ladda ner fulltext (pdf) av Effects of an anti-lipogenic low-carbohydrate high polyunsaturated fat diet or a healthy Nordic diet versus usual care on liver fat and cardiometabolic disorders in type 2 diabetes or prediabetes: a randomized controlled trial (NAFLDiet)

Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study

Blomdahl, Julia; Åberg, Mikael; Fridén, Michael; Ahlström, Håkan et al.

Ingår i Scandinavian Journal of Gastroenterology, s. 597-605, 2025

• DOI för Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study
• Ladda ner fulltext (pdf) av Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study

Ultrasound for the Detection of Gallbladder Malignancy in Primary Sclerosing Cholangitis

Altenmuller, Johannes; Wiegard, Christiane; Sebode, Marcial; Lohse, Ansgar W. et al.

Ingår i Liver international, 2025

• DOI för Ultrasound for the Detection of Gallbladder Malignancy in Primary Sclerosing Cholangitis
• Ladda ner fulltext (pdf) av Ultrasound for the Detection of Gallbladder Malignancy in Primary Sclerosing Cholangitis

Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease

Shang, Ying; Akbari, Camilla; Dodd, Maja; Zhang, Xiao et al.

Ingår i Hepatology, s. 1501-1511, 2025

• DOI för Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease

Dietary Habits of Individuals With Primary Sclerosing Cholangitis-Poor Fat-Soluble Vitamin Intake and Dietary Quality

Lindqvist, Catarina; Ingre, Michael; Kechagias, Stergios; Nilsson, Emma et al.

Ingår i Liver international, 2025

• DOI för Dietary Habits of Individuals With Primary Sclerosing Cholangitis-Poor Fat-Soluble Vitamin Intake and Dietary Quality
• Ladda ner fulltext (pdf) av Dietary Habits of Individuals With Primary Sclerosing Cholangitis-Poor Fat-Soluble Vitamin Intake and Dietary Quality

Effects of an anti-lipogenic low-carbohydrate high polyunsaturated fat diet or a healthy Nordic diet versus usual care on liver fat and cardiometabolic disorders in type 2 diabetes or prediabetes: a randomized controlled trial (NAFLDiet)

Fridén, Michael; Rosqvist, Fredrik; Kullberg, Joel; Berglund, Lars et al.

Ingår i Nature Communications, 2025

• DOI för Effects of an anti-lipogenic low-carbohydrate high polyunsaturated fat diet or a healthy Nordic diet versus usual care on liver fat and cardiometabolic disorders in type 2 diabetes or prediabetes: a randomized controlled trial (NAFLDiet)
• Ladda ner fulltext (pdf) av Effects of an anti-lipogenic low-carbohydrate high polyunsaturated fat diet or a healthy Nordic diet versus usual care on liver fat and cardiometabolic disorders in type 2 diabetes or prediabetes: a randomized controlled trial (NAFLDiet)

Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study

Blomdahl, Julia; Åberg, Mikael; Fridén, Michael; Ahlström, Håkan et al.

Ingår i Scandinavian Journal of Gastroenterology, s. 597-605, 2025

• DOI för Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study
• Ladda ner fulltext (pdf) av Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study

Ultrasound for the Detection of Gallbladder Malignancy in Primary Sclerosing Cholangitis

Altenmuller, Johannes; Wiegard, Christiane; Sebode, Marcial; Lohse, Ansgar W. et al.

Ingår i Liver international, 2025

• DOI för Ultrasound for the Detection of Gallbladder Malignancy in Primary Sclerosing Cholangitis
• Ladda ner fulltext (pdf) av Ultrasound for the Detection of Gallbladder Malignancy in Primary Sclerosing Cholangitis

Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease

Shang, Ying; Akbari, Camilla; Dodd, Maja; Zhang, Xiao et al.

Ingår i Hepatology, s. 1501-1511, 2025

• DOI för Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease

Health-related quality of life in patients with liver cirrhosis following adjunctive nurse-based care versus standard medical care: a pragmatic, multicentre, randomised controlled study

Hjorth, Maria; Sjöberg, Daniel; Svanberg, Anncarin; Lo Martire, Riccardo et al.

Ingår i BMJ Open Gastroenterology, 2025

• DOI för Health-related quality of life in patients with liver cirrhosis following adjunctive nurse-based care versus standard medical care: a pragmatic, multicentre, randomised controlled study
• Ladda ner fulltext (pdf) av Health-related quality of life in patients with liver cirrhosis following adjunctive nurse-based care versus standard medical care: a pragmatic, multicentre, randomised controlled study

Patient perceived quality of cirrhosis care – adjunctive nurse-based care versus standard medical care: a pragmatic multicentre randomised controlled study

Hjorth, Maria; Svanberg, Anncarin; LoMartire, Riccardo; Kaminsky, Elenor et al.

Ingår i BMC Nursing, 2024

• DOI för Patient perceived quality of cirrhosis care – adjunctive nurse-based care versus standard medical care: a pragmatic multicentre randomised controlled study
• Ladda ner fulltext (pdf) av Patient perceived quality of cirrhosis care – adjunctive nurse-based care versus standard medical care: a pragmatic multicentre randomised controlled study

Cause of death by fibrosis stage in 959 patients with biopsy-proven NAFLD

Shang, Ying; Akbari, Camilla; Dodd, Maja; Nasr, Patrik et al.

Ingår i Gut, 2024

• DOI för Cause of death by fibrosis stage in 959 patients with biopsy-proven NAFLD

The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)

Cornillet, Martin; Villard, Christina; Rorsman, Fredrik; Molinaro, Antonio et al.

Ingår i eClinicalMedicine, 2024

• DOI för The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)
• Ladda ner fulltext (pdf) av The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)

Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD

Akbari, Camilla; Dodd, Maja; Stål, Per; Nasr, Patrik et al.

Ingår i JHEP Reports, 2024

• DOI för Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD
• Ladda ner fulltext (pdf) av Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD

Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells

Kopsida, Maria; Clavero, Ada Lerma; Khaled, Jaafar; Balgoma, David et al.

Ingår i Molecular Metabolism, 2024

• DOI för Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells
• Ladda ner fulltext (pdf) av Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells

Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis

Villard, Christina; Friis-Liby, Ingalill; Rorsman, Fredrik; Said, Karouk et al.

Ingår i Journal of Hepatology, s. 604-613, 2023

• DOI för Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis
• Ladda ner fulltext (pdf) av Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis

Impact on follow-up strategies in patients with primary sclerosing cholangitis

Bergquist, Annika; Weismueller, Tobias J.; Levy, Cynthia; Rupp, Christian et al.

Ingår i Liver international, s. 127-138, 2023

• DOI för Impact on follow-up strategies in patients with primary sclerosing cholangitis
• Ladda ner fulltext (pdf) av Impact on follow-up strategies in patients with primary sclerosing cholangitis

Feeling safe or falling through the cracks – Patients’ experiences of healthcare in cirrhosis illness: A qualitative study

Hjorth, Maria; Svanberg, Anncarin; Sjöberg, Daniel; Rorsman, Fredrik et al.

Ingår i PLOS ONE, 2023

• DOI för Feeling safe or falling through the cracks – Patients’ experiences of healthcare in cirrhosis illness: A qualitative study
• Ladda ner fulltext (pdf) av Feeling safe or falling through the cracks – Patients’ experiences of healthcare in cirrhosis illness: A qualitative study

Fatty acids in multiple circulating lipid fractions reflects the composition of liver triglycerides in humans

Rosqvist, Fredrik; Fridén, Michael; Vessby, Johan; Hockings, Paul et al.

Ingår i Clinical Nutrition, s. 805-809, 2022

• DOI för Fatty acids in multiple circulating lipid fractions reflects the composition of liver triglycerides in humans
• Ladda ner fulltext (pdf) av Fatty acids in multiple circulating lipid fractions reflects the composition of liver triglycerides in humans

Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease

Fridén, Michael; Rosqvist, Fredrik; Ahlström, Håkan; Niessen, Heiko G. et al.

Ingår i Frontiers in Medicine, 2022

• DOI för Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease
• Ladda ner fulltext (pdf) av Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease

AGPAT1 as a Novel Colonic Biomarker for Discriminating Between Ulcerative Colitis With and Without Primary Sclerosing Cholangitis

Vessby, Johan; Wisniewski, Jacek R.; Lindskog, Cecilia; Eriksson, Niclas et al.

Ingår i Clinical and Translational Gastroenterology, 2022

• DOI för AGPAT1 as a Novel Colonic Biomarker for Discriminating Between Ulcerative Colitis With and Without Primary Sclerosing Cholangitis

Circulating fatty acids from high-throughput metabolomics platforms as potential biomarkers of dietary fatty acids

Rosqvist, Fredrik; Fridén, Michael; Vessby, Johan; Rorsman, Fredrik et al.

Ingår i Clinical Nutrition, s. 2637-2643, 2022

• DOI för Circulating fatty acids from high-throughput metabolomics platforms as potential biomarkers of dietary fatty acids
• Ladda ner fulltext (pdf) av Circulating fatty acids from high-throughput metabolomics platforms as potential biomarkers of dietary fatty acids

Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis

Grigoriadis, Aristeidis; Ringe, Kristina Imeen; Bengtsson, Johan; Baubeta, Erik et al.

Ingår i JHEP Reports, 2022

• DOI för Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis
• Ladda ner fulltext (pdf) av Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis

Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival

Sennefelt Nyman, Sofi; Ahlström, Håkan; Dimopoulou, Angeliki; Dahlgren, David et al.

Ingår i BMJ Open, 2022

• DOI för Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival
• Ladda ner fulltext (pdf) av Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival

Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome

Efe, Cumali; Torgutalp, Murat; Henriksson, Ida; Alalkim, Fatema et al.

Ingår i Journal of Gastroenterology and Hepatology, s. 936-942, 2021

• DOI för Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome

A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy

Montagnese, Sara; Lauridsen, Mette; Vilstrup, Hendrik; Zarantonello, Lisa et al.

Ingår i Journal of Hepatology, s. 98-107, 2021

• DOI för A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy
• Ladda ner fulltext (pdf) av A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy

Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers

Hagström, Hannes; Ndegwa, Nelson; Jalmeus, Molly; Ekstedt, Mattias et al.

Ingår i Liver international, s. 545-553, 2021

• DOI för Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers
• Ladda ner fulltext (pdf) av Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers

Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis

Hedin, Charlotte Rose Hawkey; Sado, Gina; Ndegwa, Nelson; Lytvyak, Ellina et al.

Ingår i Clinical Gastroenterology and Hepatology, s. 2295-230400, 2020

• DOI för Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis

Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions: a retrospective evaluation

Ebeling Barbier, Charlotte; Rorsman, Fredrik; Eriksson, Lars-Gunnar; Sangfelt, Per et al.

Ingår i Acta Radiologica, Supplement, 2020

• DOI för Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions: a retrospective evaluation
• Ladda ner fulltext (pdf) av Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions: a retrospective evaluation

Liver cirrhosis turns life into an unpredictable roller-coaster: A qualitative interview study

Hjorth, Maria; Svanberg, Anncarin; Sjöberg, Daniel; Rorsman, Fredrik et al.

Ingår i Journal of Clinical Nursing, s. 4532-4543, 2020

• DOI för Liver cirrhosis turns life into an unpredictable roller-coaster: A qualitative interview study
• Ladda ner fulltext (pdf) av Liver cirrhosis turns life into an unpredictable roller-coaster: A qualitative interview study

High serum sCD40 and a distinct colonic T cell profile in ulcerative colitis associated with primary sclerosing cholangitis.

Lampinen, Maria; Vessby, Johan; Fredricsson, Annika; Wanders, Alkwin et al.

Ingår i Journal of Crohn's & Colitis, s. 341-350, 2019

• DOI för High serum sCD40 and a distinct colonic T cell profile in ulcerative colitis associated with primary sclerosing cholangitis.

Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis

Efe, Cumali; Tascilar, Koray; Henriksson, Ida; Lytvyak, Ellina et al.

Ingår i American Journal of Gastroenterology, s. 1101-1108, 2019

• DOI för Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis

Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.

Vessby, Johan; Lampinen, Maria; Åberg, Mikael; Rorsman, Fredrik et al.

Ingår i Upsala Journal of Medical Sciences, s. 238-245, 2019

• DOI för Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.

Downregulated eosinophil activity in ulcerative colitis with concomitant primary sclerosing cholangitis

Lampinen, Maria; Fredricsson, Annika; Vessby, Johan; Martinez, Johana Fernandez et al.

Ingår i Journal of Leukocyte Biology, s. 173-183, 2018

• DOI för Downregulated eosinophil activity in ulcerative colitis with concomitant primary sclerosing cholangitis

Nurse-led clinic for patients with liver cirrhosis-effects on health-related quality of life: study protocol of a pragmatic multicentre randomised controlled trial.

Hjorth, Maria; Sjöberg, Daniel; Svanberg, Anncarin; Kaminsky, Elenor et al.

Ingår i BMJ Open, 2018

• DOI för Nurse-led clinic for patients with liver cirrhosis-effects on health-related quality of life: study protocol of a pragmatic multicentre randomised controlled trial.
• Ladda ner fulltext (pdf) av Nurse-led clinic for patients with liver cirrhosis-effects on health-related quality of life: study protocol of a pragmatic multicentre randomised controlled trial.

Treatment of acute portomesenteric venous thrombosis with thrombectomy through a transjugular intrahepatic portosystemic shunt: a single-center experience.

Rosenqvist, Kerstin; Ebeling Barbier, Charlotte; Rorsman, Fredrik; Sangfelt, Per et al.

Ingår i Acta Radiologica, s. 953-958, 2018

• DOI för Treatment of acute portomesenteric venous thrombosis with thrombectomy through a transjugular intrahepatic portosystemic shunt: a single-center experience.

Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis

Borssen, Åsa Danielsson; Marschall, Hanns-Ulrich; Bergquist, Annika; Rorsman, Fredrik et al.

Ingår i Scandinavian Journal of Gastroenterology, s. 1022-1028, 2017

• DOI för Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis

Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease

Hagström, Hannes; Nasr, Patrik; Ekstedt, Mattias; Kechagias, Stergios et al.

Ingår i Scandinavian Journal of Gastroenterology, s. 159-165, 2017

• DOI för Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease

Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis A cohort study

Borssen, Åsa D.; Palmqvist, Richard; Kechagias, Stergios; Marschall, Hanns-Ulrich et al.

Ingår i Medicine, 2017

• DOI för Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis A cohort study
• Ladda ner fulltext (pdf) av Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis A cohort study

Transjugular intrahepatic portosystemic shunt treatment of variceal bleeding in an unselected patient population

Rosenqvist, Kerstin; Sheikhi, Reza; Nyman, Rickard; Rorsman, Fredrik et al.

Ingår i Scandinavian Journal of Gastroenterology, s. 70-75, 2017

• DOI för Transjugular intrahepatic portosystemic shunt treatment of variceal bleeding in an unselected patient population

Autoantibodies Targeting a Collecting Duct-Specific Water Channel in Tubulointerstitial Nephritis.

Landegren, Nils; Pourmousa Lindberg, Mina; Skov, Jakob; Hallgren, Åsa et al.

Ingår i Journal of the American Society of Nephrology, s. 3220-3228, 2016

• DOI för Autoantibodies Targeting a Collecting Duct-Specific Water Channel in Tubulointerstitial Nephritis.

Expression of the liver homing receptor CXCR3+on colonic CD8+T lymphocytes in patients with primary sclerosing cholangitis provides a possible link between colonic and biliary duct inflammation

Lampinen, Maria; Fredricsson, Annika; Vessby, Johan; Wanders, A. et al.

Ingår i Journal of Crohn's & Colitis, 2016

Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease

Hagström, Hannes; Nasr, Patrik; Ekstedt, Mattias; Kechagias, Stergios et al.

Ingår i Hepatology, 2016

Active cytomegalovirus infection diagnosed by real-time PCR in patients with inflammatory bowel disease: a prospective, controlled observational study

Thörn, Mari; Rorsman, Fredrik; Rönnblom, Anders; Sangfelt, Per et al.

Ingår i Scandinavian Journal of Gastroenterology, s. 1075-1080, 2016

• DOI för Active cytomegalovirus infection diagnosed by real-time PCR in patients with inflammatory bowel disease: a prospective, controlled observational study

Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver

Rosenqvist, Kerstin; Eriksson, Lars-Gunnar; Rorsman, Fredrik; Sangfelt, Per et al.

Ingår i Acta Radiologica, s. 572-579, 2016

• DOI för Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver

Endovascular treatment of symptomatic Budd-Chiari syndrome - in favour of early transjugular intrahepatic portosystemic shunt.

Rosenqvist, Kerstin; Sheikhi, Reza; Eriksson, Lars-Gunnar; Rajani, Rupesh et al.

Ingår i European Journal of Gastroenterology and Hepathology, s. 656-660, 2016

• DOI för Endovascular treatment of symptomatic Budd-Chiari syndrome - in favour of early transjugular intrahepatic portosystemic shunt.

Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region)

Rönnblom, Anders; Holmstrom, Tommy; Tanghoj, Hans; Rorsman, Fredrik et al.

Ingår i Journal of Gastroenterology and Hepatology, s. 1288-1292, 2015

• DOI för Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region)

Monitoring Dominant Strictures in Primary Sclerosing Cholangitis with Brush Cytology and FDG-PET

Sangfelt, Per; Sundin, Anders; Wanders, Alkwin; Rasmussen, Ib et al.

Ingår i Journal of Hepatology, s. 1352-1357, 2014

• DOI för Monitoring Dominant Strictures in Primary Sclerosing Cholangitis with Brush Cytology and FDG-PET

Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model

Ahlgren, Kerstin M.; Moretti, Silvia; Lundgren, Brita Ardesjö; Karlsson, Iulia et al.

Ingår i European Journal of Immunology, s. 235-245, 2011

• DOI för Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model

Identification of complement C3 as an autoantigen in inflammatory bowel disease

Ardesjö Lundgren, Brita; Rorsman, Fredrik; Portela-Gomes, Guida M.; Grimelius, Lars et al.

Ingår i European Journal of Gastroenterology and Hepathology, s. 429-436, 2010

• DOI för Identification of complement C3 as an autoantigen in inflammatory bowel disease

Identification of a novel staining pattern of bile duct epithelial cells in primary sclerosing cholangitis

Ardesjö, Brita; Portela-Gomes, Guida M.; Rorsman, Fredrik; Grimelius, Lars et al.

Ingår i Inflammatory Bowel Diseases, s. 305-311, 2010

• DOI för Identification of a novel staining pattern of bile duct epithelial cells in primary sclerosing cholangitis

Pulmonary Autoimmunity as a Feature of Autoimmune Polyendocrine Syndrome Type 1 and Identification of KCNRG as a Bronchial Autoantigen

Alimohammadi, Mohammad; Dubois, Noemie; Sköldberg, Filip; Hallgren, Åsa et al.

Ingår i Proceedings of the National Academy of Sciences of the United States of America, s. 4396-4401, 2009

• DOI för Pulmonary Autoimmunity as a Feature of Autoimmune Polyendocrine Syndrome Type 1 and Identification of KCNRG as a Bronchial Autoantigen

Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis

Classen, Jean-Francois; Henrohn, Dan; Rorsman, Fredrik; Lennartsson, Johan et al.

Ingår i Arthritis and Rheumatism, s. 1137-1144, 2009

• DOI för Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis

Scleroderma

Demoulin, Jean-Baptiste; Kämpe, Olle; Rorsman, Fredrik

Ingår i New England Journal of Medicine, s. 826-827, 2009

• DOI för Scleroderma

Impaired autoimmune T helper 17 cell responses following DNA vaccination against rat experimental autoimmune encephalomyelitis

Andersson, Åsa; Isaksson, Magnus; Wefer, Judit; Norling, Anna et al.

Ingår i PLOS ONE, 2008

• DOI för Impaired autoimmune T helper 17 cell responses following DNA vaccination against rat experimental autoimmune encephalomyelitis

Autoantibodies to Glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases

Ardesjö, Brita; Hansson, Caisa M.; Bruder, Carl E.G.; Rorsman, Fredrik et al.

Ingår i Journal of Autoimmunity, s. 273-282, 2008

• DOI för Autoantibodies to Glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases

Immunoreactivity against goblet cells in patients with inflammatory bowel disease

Ardesjö, Brita; Portela-Gomes, Guida M.; Rorsman, Fredrik; Gerdin, Eva et al.

Ingår i Inflammatory Bowel Diseases, s. 652-661, 2008

• DOI för Immunoreactivity against goblet cells in patients with inflammatory bowel disease

Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis

Lampinen, Maria; Backman, Marie; Winqvist, Ola; Rorsman, Fredrik et al.

Ingår i Journal of Leukocyte Biology, s. 1392-1399, 2008

• DOI för Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis

Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen

Alimohammadi, Mohammad; Björklund, Peyman; Hallgren, Åsa; Pöntynen, Nora et al.

Ingår i New England Journal of Medicine, s. 1018-1028, 2008

• DOI för Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen

Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1)

Englund, Gunilla; Jacobson, Annica; Rorsman, Fredrik; Artursson, Per et al.

Ingår i Inflammatory Bowel Diseases, s. 291-297, 2007

• DOI för Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1)

Autoantibodies linked to autoimmune polyendocrine syndrome type I are prevalent in Down syndrome

Söderbergh, Annika; Gustafsson, Jan; Ekwall, Olov; Hallgren, Åsa et al.

Ingår i Acta Paediatrica, s. 1657-1660, 2006

• DOI för Autoantibodies linked to autoimmune polyendocrine syndrome type I are prevalent in Down syndrome

Regional levels of drug transporters along the human intestinal tract: Co-expression of ABC and SLC transporters and comparison with Caco-2 cells

Englund, Gunilla; Rorsman, Fredrik; Rönnblom, Anders; Karlbom, Urban et al.

Ingår i European Journal of Pharmaceutical Sciences, s. 269-277, 2006

• DOI för Regional levels of drug transporters along the human intestinal tract: Co-expression of ABC and SLC transporters and comparison with Caco-2 cells

Eosinophil granulocytes are activated during the remission phase of ulcerative colitis.

Lampinen, Maria; Rönnblom, Anders; Amin, Kawa; Kristjansson, Gudjon et al.

Ingår i Gut, 2005

APSI - svår autoimmun sjukdom med endokrina och icke-endokrina symtom

Gustafsson, Jan; Alimohammadi, Mohammad; Ekwall, Olov; Gebre-Medhin, Gennet et al.

Ingår i Läkartidningen, s. 2096-2103, 2004

Analysis of antibody reactivity against cysteine sulfinic acid decarboxylase, a pyridoxal phosphate-dependent enzyme, in endocrine autoimmune disease

Sköldberg, Filip; Rorsman, Fredrik; Perheentupa, Jaakko; Landin-Olsson, Mona et al.

Ingår i Journal of Clinical Endocrinology and Metabolism, s. 1636-1640, 2004

• DOI för Analysis of antibody reactivity against cysteine sulfinic acid decarboxylase, a pyridoxal phosphate-dependent enzyme, in endocrine autoimmune disease

No evidence for autoimmunity as a major cause of the empty sella syndrome

Bensing, Sophie; Rorsman, Fredrik; Crock, P.; Sanjeevi, C. et al.

Ingår i Experimental and clinical endocrinology & diabetes, s. 231-235, 2004

Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells

Sköldberg, Filip; Portela-Gomes, Guida M.; Grimelius, Lars; Nilsson, Gunnar et al.

Ingår i Journal of Clinical Endocrinology and Metabolism, s. 1445-1452, 2003

• DOI för Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells

Identification of AHNAK as a novel autoantigen in systemic lupuserythematosus

Sköldberg, Filip; Rönnblom, Lars; Thornemo, M; Lindahl, A et al.

Ingår i Biochemical and Biophysical Research Communications - BBRC, s. 951-958, 2002

• DOI för Identification of AHNAK as a novel autoantigen in systemic lupuserythematosus

AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype

Halonen, M; Eskelin, P; Myhre, AG; Perheentupa, J et al.

Ingår i Journal of Clinical Endocrinology and Metabolism, s. 2568, 2002

• DOI för AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype

Autoantibodies against aromatic L-amino acid decarboxylase identifies a subgroup of patients with Addison's disease

Söderbergh, A; Rorsman, F; Halonen, M; Ekwall, O et al.

Ingår i J Clin Endocrinol Metab, s. 460-463, 2000

A family with hereditary extra-adrenal paragangliomas without evidence for mutations in the von Hippel-Lindau disease or ret genes

Sköldberg, Filip; Grimelius, Lars; Woodward, E R; Rorsman, Fredrik et al.

Ingår i Clinical Endocrinology, s. 11-16, 1998

• DOI för A family with hereditary extra-adrenal paragangliomas without evidence for mutations in the von Hippel-Lindau disease or ret genes

Forty years of successful national research collaboration in liver disease: the Swedish experience

Bergquist, Annika; Ekstedt, Mattias; Hagström, Hannes; Järnerot, Gunnar et al.

Ingår i Scandinavian Journal of Gastroenterology, s. 1314-1321, 2024

• DOI för Forty years of successful national research collaboration in liver disease: the Swedish experience
• Ladda ner fulltext (pdf) av Forty years of successful national research collaboration in liver disease: the Swedish experience

Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems

Fetissov, Sergueï O.; Bensing, Sophie; Mulder, Jan; Le Maitre, Erwan et al.

Ingår i Journal of Comparative Neurology, s. 1-20, 2009

• DOI för Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems

mRNA expression of drug-transporting proteins along the human intestine and comparison with expression in Caco-2 cells

Englund, Gunilla; Rorsman, Fredrik; Rönnblom, Anders; Lazorova, Lucia et al.

2012

A two-step proteomic approach identifies candidate biomarker in ulcerative colitis with concomitant primary sclerosing cholangitis.

Vessby, Johan; Wisniewski, Jacek; Eriksson, Niclas; Gabrysch, Katja et al.

Pharmacological inhibition of PERK during early carcinogenesis restrains tumor progression and remodels the tumor microenvironment in hepatocellular carcinoma

Khaled, Jaafar; Kopsida, Maria; Payo Serafín, Tania; Sennefelt Nyman, Sofi et al.

Characterization of hepatocellular carcinoma patient-derived organoids receiving transarterial chemoembolization as a preclinical model for drug response assessment

Khaled, Jaafar; Sennefelt Nyman, Sofi; Rorsman, Fredrik; Lennernäs, Hans et al.